Rupen Hargreaves

机构：University of Oxford, MRC Weatherall Institute of Molecular Medicine, MRC Human Immunology Unit, Oxford BioMedica (United Kingdom) · ORCID：0000-0002-3326-9829

发表论文 11 篇 · 总被引 38 次 · h-index 4

代表论文

• comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disorders (2026 · Cell stem cell · 被引 9)
• How I manage myeloproliferative neoplasm‐unclassifiable: Practical approaches for 2022 and beyond (2022 · British Journal of Haematology · 被引 9)
• Inflammation reprogramming and immunomodulation: Next-generation treatments for atherosclerosis (2025 · Cell Reports Medicine · 被引 8)
• Diagnostic and management strategies for Myeloproliferative Neoplasm-Unclassifiable (MPN-U): An international survey of contemporary practice (2022 · Current Research in Translational Medicine · 被引 5)
• comBO: A combined human bone and lympho-myeloid bone marrow organoid for pre-clinical modelling of haematopoietic disorders (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 3)
• Challenges of diagnosing and managing pre-fibrotic myelofibrosis: A case-based and practical approach (2022 · Best Practice & Research Clinical Haematology · 被引 3)